Tenon Medical, Inc.
TNON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,277 | $2,928 | $691 | $160 |
| % Growth | 11.9% | 323.7% | 331.9% | – |
| Cost of Goods Sold | $1,566 | $1,687 | $1,332 | $55 |
| Gross Profit | $1,711 | $1,241 | -$641 | $105 |
| % Margin | 52.2% | 42.4% | -92.8% | 65.6% |
| R&D Expenses | $2,603 | $3,163 | $2,828 | $1,718 |
| G&A Expenses | $7,765 | $7,027 | $7,423 | $2,707 |
| SG&A Expenses | $12,874 | $13,805 | $15,256 | $4,848 |
| Sales & Mktg Exp. | $5,109 | $6,778 | $7,833 | $2,141 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $15,477 | $16,968 | $18,084 | $6,566 |
| Operating Income | -$13,766 | -$15,727 | -$18,725 | -$6,461 |
| % Margin | -420.1% | -537.1% | -2,709.8% | -4,038.1% |
| Other Income/Exp. Net | $93 | $146 | -$192 | -$620 |
| Pre-Tax Income | -$13,673 | -$15,581 | -$18,917 | -$7,081 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13,673 | -$15,581 | -$18,917 | -$7,048 |
| % Margin | -417.2% | -532.1% | -2,737.6% | -4,405% |
| EPS | -11.26 | -68.64 | -187.3 | -624.38 |
| % Growth | 83.6% | 63.4% | 70% | – |
| EPS Diluted | -11.26 | -68.64 | -187.3 | -624.38 |
| Weighted Avg Shares Out | 1,214 | 227 | 101 | 11 |
| Weighted Avg Shares Out Dil | 1,214 | 227 | 101 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $34 | $21 | $354 | $621 |
| Depreciation & Amortization | $655 | $426 | $289 | $114 |
| EBITDA | -$12,984 | -$15,134 | -$18,274 | -$6,346 |
| % Margin | -396.2% | -516.9% | -2,644.6% | -3,966.3% |